P-164 Reduction in disease symptoms/impacts after daratumumab, lenalidomide, bortezomib, and dexamethasone treatment for transplant-eligible patients with newly diagnosed multiple myeloma (GRIFFIN study)
Year: 2023
Type: conference-abstract
Authors: Rebecca Silbermann, Jacob Laubach, Jonathan Kaufman, Douglas Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Luciano Costa, Larry Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Caitlin Costello, Andrzej Jakubowiak, Robert Orlowski, Ken Shain, Katharine Gries, Huiling Pei, Annelore Cortoos, Sharmila Patel, Kathryn Matt, Thomas Lin, Saad Usmani, Peter Voorhees, Paul Richardson
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4387003587